Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment
about
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patientsEGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeThe clinical phenotype of Lynch syndrome due to germ-line PMS2 mutationsPMS2 monoallelic mutation carriers: the known unknownCommon variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.Risks of Lynch syndrome cancers for MSH6 mutation carriers.Cancer risks for MLH1 and MSH2 mutation carriers.Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relativesCancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management.Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: A retrospective case-case study.Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genesAge-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.Risk of pancreatic cancer in families with Lynch syndrome.Hereditary colon cancer: lynch syndromeCommunication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study.The mutational spectrum of Lynch syndrome in cyprus.Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinomaInterval colon cancer in a Lynch syndrome patient under annual colonoscopic surveillance: a case for advanced imaging techniques?Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome familiesEstimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) methodFamilial colorectal cancer, beyond Lynch syndromeDietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.Understanding patterns of health communication in families at risk for hereditary nonpolyposis colorectal cancer: examining the effect of conclusive versus indeterminate genetic test resultsQuality of colonoscopy in Lynch syndromeDependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes.Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.Microsatellite instability use in mismatch repair gene sequence variant classificationWhole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.Do hereditary syndrome-related gynecologic cancers have any specific features?Pancreatic cancer and a novel MSH2 germline alteration.Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromesRisks of primary extracolonic cancers following colorectal cancer in lynch syndromeA multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.
P2860
Q21328691-8E5C6FF4-E4D9-48C2-B080-EC9DF2FE1429Q24655053-C42FCCF7-CB24-4CB6-8DDB-BB173D7A05FEQ24655454-AC5F2F05-834C-4D89-A416-61D0550AB675Q27024662-57AB232E-BC41-4FC3-AAA6-A8F99ADF6A9DQ29417133-CA35512F-98FC-4707-9E15-BBDE769B8B0BQ30492977-3A1FD931-3F61-4194-BF2C-87B2C96B5901Q30563768-A184E36C-16B2-4E87-8838-B87E3AFF7FE5Q31139897-7F50E0FA-395A-4025-A516-972E4F344AB1Q33582756-7C6A2203-EB0B-4D25-94D3-DD075F566BABQ33658220-F528AA2D-E5D0-459C-8E8C-58807E8AE95AQ33685573-C9B155B0-CA5B-41D7-9CBF-846FA169E898Q33779382-EF1898A1-676E-449F-8ABB-34A3BC1CDE6CQ33807931-A18E61C9-E51B-48F2-8DFF-666F9D7F13BDQ33880380-C6B1819A-1AE3-4B21-9D66-C05E94E7A80FQ33918280-B718ED39-9354-49A4-8F82-6B714ED790AAQ34051401-7DCE553F-A116-4127-A6BA-18E1AFBEC94FQ34062115-88C8D5A0-7491-485A-B899-121C6EEFC9BAQ34163849-97538D8E-BB30-4941-8AA4-E8C300A17A04Q34280607-513CA9C8-2E72-499C-9E2C-4FC8E68A538FQ34344817-C6ED6EE0-A310-450A-80DB-36A182F9E7CBQ34346668-16F8B502-9D4F-4988-A39B-FD4A74E2435BQ34501718-E2520964-AD95-473B-8F6E-22ADB5E2B4F4Q34514962-137A601F-9AD4-46DC-92B5-3451898D775CQ34655489-8F6895B5-FA1B-4959-B5FC-9F8FF2EDCE25Q34794283-CB1D3041-FCFF-4903-B885-253CA49400E3Q34977063-7831A705-17B5-482B-AE7F-14203C2D214EQ34988799-2695A2FA-355E-444A-8161-51CD2F74408DQ35013990-95E5ACB0-AF23-43FF-9C68-C53159C89026Q35129795-B79B2B04-9195-4E90-9C00-830E5D984A1CQ35579543-038DC69B-DB73-4E2A-A445-699E707EB21EQ35587019-3B6B6E46-8A6E-449F-95D9-6F9D13F35FA2Q35760971-9EA4D876-6CAD-4C9D-97E4-B63EB3325DA8Q35808472-DDF42703-13E6-410E-A050-A5CD7C57C959Q36051960-DFA3FF33-70C3-4571-8B7F-A225AB5E6AB9Q36059087-7EF63176-53D0-4B17-84D7-3FADDC563683Q36182997-44C45ECC-01C8-4AE0-A283-DC18387DE1BCQ36288221-BC099EE7-6C12-479A-9F72-04082BB91349Q36416282-DEE5C7B9-3765-4DED-B660-27FD809EA09BQ36486798-B4744727-83D5-41E3-9D87-C4606434206BQ36512734-D1D7F322-6467-4AE9-9E37-03ED687FB252
P2860
Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk of colorectal and endomet ...... : correction for ascertainment
@ast
Risk of colorectal and endomet ...... : correction for ascertainment
@en
type
label
Risk of colorectal and endomet ...... : correction for ascertainment
@ast
Risk of colorectal and endomet ...... : correction for ascertainment
@en
prefLabel
Risk of colorectal and endomet ...... : correction for ascertainment
@ast
Risk of colorectal and endomet ...... : correction for ascertainment
@en
P3181
P356
P1476
Risk of colorectal and endomet ...... : correction for ascertainment
@en
P2093
F Quehenberger
P304
P3181
P356
10.1136/JMG.2004.024299
P407
P577
2005-06-01T00:00:00Z